Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...

First introduced by Mainz Biomed in mid-2024, the enhanced ColoAlert features state-of-the-art advancements, including a proprietary DNA stabilizing buffer, to deliver accurate results even with ...

Union Budget boosts research and innovation with significant funding for science, technology, and biotechnology sectors.

The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

In a move temporarily suspended by a judge, National Institutes of Health is attempting to limit administrative fees of ...

The Detroit rapper, speaks out on Lyft discrimination and advocates for better accommodations for plus-sized people.

A hill flock has survived a major enterprise restructure on an Exmoor farm, which saw cow numbers increased at the expense of ...

For the first time, University of Hawaiʻi at Mānoa researchers have studied how work, volunteering and leisure activities ...

Evolution is traditionally associated with a process of increasing complexity and gaining new genes. However, the explosion ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.